Millennium Pharmacon International Asset Resilience Ratio
Millennium Pharmacon International asset resilience ratio. Millennium Pharmacon International (SDPC) has an Asset Resilience Ratio of -0.72% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SDPC days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Millennium Pharmacon International (2000–2021)
Asset resilience ratio of Millennium Pharmacon International from 2000 to 2021. This chart shows how Millennium Pharmacon International's Asset Resilience Ratio has changed over time. Read SDPC current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Millennium Pharmacon International's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Millennium Pharmacon International.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 0% |
| Short-term Investments | Rp-11.22 Billion | -0.72% |
| Total Liquid Assets | Rp-11.22 Billion | -0.72% |
Asset Resilience Insights
- Limited Liquidity: Millennium Pharmacon International maintains only -0.72% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Millennium Pharmacon International Industry Peers by Asset Resilience Ratio
Compare Millennium Pharmacon International's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
SINOPHARM GROUP 1/5/O.N.
F:X2S1 |
Medical Distribution | 0.00% |
|
Selcuk Ecza Deposu Ticaret ve Sanayi AS
IS:SELEC |
Medical Distribution | 7.12% |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
Millennium Pharmacon International Asset Resilience Ratio by Year (2000–2021)
Millennium Pharmacon International asset resilience ratio by year from 2000 to 2021. The table below shows the annual Asset Resilience Ratio data for Millennium Pharmacon International.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | -1.73% | Rp-20.88 Billion ≈ $-1.22 Million |
Rp1.21 Trillion ≈ $70.69 Million |
+0.54pp |
| 2020-12-31 | -2.27% | Rp-26.47 Billion ≈ $-1.55 Million |
Rp1.16 Trillion ≈ $68.25 Million |
+0.39pp |
| 2019-12-31 | -2.66% | Rp-32.71 Billion ≈ $-1.92 Million |
Rp1.23 Trillion ≈ $72.12 Million |
-1.24pp |
| 2018-12-31 | -1.42% | Rp-16.91 Billion ≈ $-990.95K |
Rp1.19 Trillion ≈ $69.90 Million |
+0.27pp |
| 2017-12-31 | -1.69% | Rp-15.86 Billion ≈ $-929.61K |
Rp938.01 Billion ≈ $54.96 Million |
-1.71pp |
| 2002-12-31 | 0.01% | Rp15.90 Million ≈ $931.50 |
Rp108.27 Billion ≈ $6.34 Million |
-2.88pp |
| 2000-12-31 | 2.89% | Rp3.28 Billion ≈ $192.10K |
Rp113.38 Billion ≈ $6.64 Million |
-- |
About Millennium Pharmacon International
PT Millennium Pharmacon International Tbk engages in the distribution of prescription and non-prescription medicines and medical devices in Indonesia. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium… Read more